Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-164.82%
operating margin TTM
-121.78%
revenue TTM
26.50 Million
revenue per share TTM
0.55$
valuation ratios | |
|---|---|
| pe ratio | -1.21 |
| peg ratio | -0.01 |
| price to book ratio | 2.66 |
| price to sales ratio | 2.06 |
| enterprise value multiple | -2.96 |
| price fair value | 2.66 |
profitability ratios | |
|---|---|
| gross profit margin | 86.43% |
| operating profit margin | -121.78% |
| pretax profit margin | -164.82% |
| net profit margin | -164.82% |
| return on assets | -143.3% |
| return on equity | -166.98% |
| return on capital employed | -156.97% |
liquidity ratios | |
|---|---|
| current ratio | 2.91 |
| quick ratio | 2.91 |
| cash ratio | 2.80 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 248.33 |
| cash conversion cycle | -248.33 |
| receivables turnover | 0.00 |
| payables turnover | 1.47 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -5.62 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.62 |
| cash per share | 0.45 |
| operating cash flow per share | -0.62 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Werewolf Therapeutics, Inc. (NASDAQ:HOWL) reported earnings?
Werewolf Therapeutics, Inc. (HOWL) published its most recent earnings results on 31-07-2026.
What is Werewolf Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Werewolf Therapeutics, Inc. (NASDAQ:HOWL)'s trailing twelve months ROE is -166.98%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Werewolf Therapeutics, Inc. (HOWL) currently has a ROA of -143.3%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HOWL's net profit margin stand at?
HOWL reported a profit margin of -164.82% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HOWL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.91 in the most recent quarter. The quick ratio stood at 2.91, with a Debt/Eq ratio of 0.00.